Can valproate sodium injection be used for absence seizures?
Valproate sodium injection is a form of valproic acid given through a vein (IV). It is approved by the FDA for treating absence seizures, including simple and complex types, and for patients with multiple seizure types that include absence seizures. The injection is used when a person cannot take valproate by mouth for a short time 6.
What the research says
The FDA has approved valproate sodium injection as an intravenous alternative for patients who temporarily cannot take oral valproate products. It is indicated for monotherapy and adjunctive therapy of simple and complex absence seizures, as well as adjunctive therapy in patients with multiple seizure types that include absence seizures 6. This approval is based on the established effectiveness of valproate for absence seizures, which is supported by multiple FDA approvals for oral forms of valproic acid and valproate 12345. Animal studies also show that valproate (including sodium valproate) inhibits absence-like seizures in rat models, confirming its anti-absence activity 789. However, the injection is specifically for short-term IV use when oral dosing is not possible, not for routine long-term treatment 6.
What to ask your doctor
- Is valproate sodium injection an option for me if I cannot take my usual oral valproate for absence seizures?
- What are the risks or side effects of switching to the IV form temporarily?
- How long can I stay on the injection before returning to oral medication?
- Are there other IV medications that work for absence seizures if valproate is not suitable?
- Does the injection have the same pregnancy warnings as oral valproate?
This question is drawn from common patient questions about Neurology and answered using cited medical research. We do not provide individualized advice.